Polynovo Limited (ASX: PNV) - ETF Exposure

Current share price for PNV : $0.880 0.015 (1.68%)⁺

Polynovo Limited (PNV) is an ASX-listed company and is held by a number of exchange traded funds (ETFs). It is engaged in the development of medical devices for medical applications, utilizing the patented bioabsorbable polymer technology NovoSorb.

PNV General Information ⁺

ASX Code	PNV
Website	N/A
Industry/Sector	Health Care Supplies
Market Cap ($M)	607
PNV Share Price	$0.880
Day High	$0.905
Day Low	$0.870
Last Close	$0.895
PNV Share Price Movement	$0.02 ( 1.68% )

Prices as at 16:40, 23 Oct 2026

⁺Security prices are delayed by at least 20 minutes and are indicative only.

Already own an Australian ETF? You may already have meaningful exposure to PNV

Polynovo Limited (PNV) is held across 11 ETFs spanning strategies that include health care supplies exposure . Its weighting in those funds means performance can have an outsized influence - when PNV moves, funds like IMPQ, ISO, SSO, VETH and VAS that hold it can move with it.

For more concentrated exposure, ETFs such as IMPQ (eInvest Better Future (Managed Fund)) allocate about 1.3% to PNV , while the average exposure across all 11 ETFs that hold it is around 0.2% .

Top ETF holdings

eInvest Better Future (Managed Fund) (IMPQ) ~ 1.3%
iShares S&P/ASX Small Ordinaries ETF Index Fund (ISO) ~ 0.2%
State Street SPDR S&P/ASX Small Ordinaries ETF (SSO) ~ 0.2%
Vanguard Ethically Conscious Australian Shares ETF (VETH) ~ 0%
Vanguard Australian Shares Index ETF (VAS) ~ 0%

Last updated: ETF data and holdings as at 24 October 2026

Own PNV directly or through an ETF?

How does holding Polynovo Limited (PNV) shares directly compare to ETFs that include it?

	PNV Direct	IMPQ ASX	ISO ASX	SSO ASX	VETH ASX	VAS ASX
Holdings	1 company	42 holdings	218 holdings	219 holdings	243 holdings	334 holdings
PNV Weight	100%	1.3%	0.2%	0.2%	0%	0%
Diversification	Single Stock	Broad	Broad	Broad	Broad	Broad
Annual Cost	Brokerage only	-	0.55% p.a.	0.5% p.a.	0.16% p.a.	0.07% p.a.
Approx. Yield	0%	-	4.78%	10.15%	2.88%	3.18%
Star Ratings	-	Not Rated

Yields and costs are approximate. ETF yields reflect the fund's dividend distributions, not PNV's direct yield. Annual cost uses each ETF's MER.

PNV Exposure on $10,000 investment

How a $10,000 investment in Polynovo Limited (PNV) one week ago compares with ETFs that hold it.

Security	Investment type	Current price	7-day price movement	Dollar change	Value today
Polynovo Limited (PNV)	Direct share	$0.880	-4.86%	-$486	$9,514
eInvest Better Future (Managed Fund) (IMPQ)	-	$3.980	0%	$0	$10,000
iShares S&P/ASX Small Ordinaries ETF Index Fund (ISO)	Equity - Australia Small/Mid Cap	$4.570	-4.19%	-$419	$9,581
State Street SPDR S&P/ASX Small Ordinaries ETF (SSO)	Equity - Australia Small/Mid Cap	$13.220	-3.99%	-$399	$9,601
Vanguard Ethically Conscious Australian Shares ETF (VETH)	Equity - Australia Strategy	$66.990	0.31%	+$31	$10,031
Vanguard Australian Shares Index ETF (VAS)	Equity - Australia	$108.570	-0.27%	-$27	$9,973

Assumes $10,000 invested 7 days ago. Figures are based on price movement only and exclude distributions, fees and brokerage.

Polynovo Limited (PNV) ETFs

11 ETFs hold Polynovo Limited (PNV).

ETF	PNV Weight	MER	Yield
eInvest Better Future (Managed Fund) (IMPQ)	1.3%	-	-
iShares S&P/ASX Small Ordinaries ETF Index Fund (ISO)	0.2%	0.55%	4.78%
State Street SPDR S&P/ASX Small Ordinaries ETF (SSO)	0.2%	0.5%	10.15%
Vanguard Ethically Conscious Australian Shares ETF (VETH)	0%	0.16%	2.88%
Vanguard Australian Shares Index ETF (VAS)	0%	0.07%	3.18%
Global X Australia 300 ETF (A300)	0%	0.03%	3.06%
Dimensional Australian Core Equity (Managed Fund) (DACE)	0%	0.28%	3.22%

View all 11 ETFs

Polynovo Limited (PNV) Upcoming Dividends & Yields

Distribution Type	Dividend	Franking	Ex-dividend date	Payment date	Current Price⁺	Price 7D Avg	Dividend Yield

See all dividends from Polynovo Limited (PNV) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Polynovo Limited (PNV) price-sensitive announcements

PNV - FY26 Full Year Results Investor Presentation

PolyNovo Limited's FY26 Full Year Results presentation highlights a strong financial perfo

Polynovo Limited (PNV)
26 Aug 2026 | 7:56 AM

PNV - ASX Announcement - FY26 Full Year Results

PolyNovo Limited, a medical technology company focused on wound care solutions, announced

Polynovo Limited (PNV)
26 Aug 2026 | 7:56 AM

PNV - FY26 Full Year Results and Appendix 4E

PolyNovo Limited reported its financial results for the fiscal year ending 30 June 2026, h

Polynovo Limited (PNV)
26 Aug 2026 | 7:55 AM

PNV - PolyNovo FY26 Trading Update

PolyNovo Limited reported a strong financial performance for FY26, with a notable 16.1% in

Polynovo Limited (PNV)
23 Jul 2026 | 8:30 AM

Polynovo Limited (PNV) Recent ASX Announcements

Company	Sector	Market Cap ($m)	Headline	Release date/time⁺	Price at release⁺	Current price⁺	Gain/Loss
Polynovo Limited (PNV) ORDINARY FULLY PAID	Health Care	$608	CFO Jan Gielen to Depart PolyNovo	20 Oct 2026 8:23AM	$0.920	$0.880	fallen by 4.35%
Polynovo Limited (PNV) ORDINARY FULLY PAID	Health Care	$608	PolyNovo Notice of Annual General Meeting	28 Sep 2026 8:51AM	$0.955	$0.880	fallen by 7.85%
Polynovo Limited (PNV) ORDINARY FULLY PAID	Health Care	$608	Dean Phizacklea and Andrew Price Appointed to PNV Board	17 Sep 2026 8:23AM	$0.955	$0.880	fallen by 7.85%
Polynovo Limited (PNV) ORDINARY FULLY PAID	Health Care	$608	PolyNovo FY26 Corporate Governance Statement	15 Sep 2026 9:01AM	$0.960	$0.880	fallen by 8.33%
Polynovo Limited (PNV) ORDINARY FULLY PAID	Health Care	$608	PolyNovo FY26 Appendix 4G	15 Sep 2026 8:59AM	$0.960	$0.880	fallen by 8.33%
Polynovo Limited (PNV) ORDINARY FULLY PAID	Health Care	$608	PolyNovo FY26 Annual Report	15 Sep 2026 8:58AM	$0.960	$0.880	fallen by 8.33%

PNV Financial Summary

Year to Jun	NPAT	EPS	EPS chg (%)	PER	Yield (%)	Franking (%)
2028F	C2	$2.00	100.00%	44.00	0.00%	0.0%
2027F	C2	$1.00	-41.90%	88.00	0.00%	0.0%
2026A	$12.06	$1.70	-9.00%	67.10	0.00%	0.0%

PNV Peer Comparison

Company	Mkt Cap	EPS Growth (%)			P/E (%)			Dividend Yield (%)
Company	Mkt Cap	2026 A	2027 F	2028 F	2026 A	2027 F	2028 F	2026 A	2027 F	2028 F
Ansell Limited (ANN)	$6,421M	0.1231	-0.0793	0.1002	21.2956	23.1310	21.0236	2.17%	1.82%	2.02%
Nanosonics Limited (NAN)	$909M	-0.1375	-0.3501	0.6933	52.6863	81.0667	47.8740	0.00%	0.00%	0.00%
Polynovo Limited (PNV)	$618M	-0.0899	-0.4186	1.0000	52.0349	89.5000	44.7500	0.00%	0.00%	0.00%

PNV Directors

Name	Position	Start Date
Mr Andrew Price	Non-Executive Director	18 Sep 2026
Dr Robyn Elliott	Non-Executive Director	28 Oct 2019
Mr Andrew Stuart Lumsden	Non-Executive Director	4 Jun 2021
Ms Christine Emmanuel-Donnelly	Non-Executive Director	13 May 2020
Dr Charmaine Hilary Gittleson	Non-Executive Director	1 Apr 2026
Mr Robert Douglas	Non-Executive Director	14 Oct 2025
Mr Dean Phizacklea	Non-Executive Director	18 Sep 2026
Mr Leon Hoare	Non-Executive Director, Non-Executive Chairman	27 Jan 2016

Polynovo Limited (PNV) Changes in Directors' Interest & Trades

Date of change	Director	Buy/Sell	Security Type	Qty	Trade Price	Value
12 Mar 2026	DOUGLAS, Robert	Buy	Indirect Shares	151,000	$0.930	$140,430.000
25 Feb 2026	HOARE, Leon	Buy	Indirect Shares	30,000	$0.936	$28,071.920
24 Feb 2026	LUMSDEN, Andrew	Buy	Indirect Shares	100,000	$0.914	$91,364.160

See all changes in directors' interest & trades for Polynovo Limited (PNV) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

PNV Management

Name	Position
Swami Raote	Chief Executive Officer
Bruce Peatey	Chief Executive Officer
Jan-Marcel Gielen	Chief Financial Officer
Jan-Marcel Gielen	Company Secretary
Amy Demediuk	General Counsel ,Company Secretary

PNV Calendar of Events

Date	Event
14 September 2027	Report (Annual)
25 August 2027	Report (Annual)
25 August 2027	Report (Prelim)
19 February 2027	Report (Interim)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.

What our members say about us